Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD4+CD25high regulatory cells in peripheral blood of cancer patients.

Neuro endocrinology letters - 1 Apr 2008

Liu Li, Wu Gang, Yao Jing-xia, Ding Qian, Huang Shi-ang

Abstract excerpt

AIM: Regulatory T cells (Treg) that prevent autoimmune diseases by suppression of self-reactive T cells may also suppress the immune response against cancer. Experimental tumor models in mice revealed that Tregs are potent inhibitors of an antitumor immune response. The purpose of the study was to identify a CD4+ population of regulatory T cells expressing high levels of CD25(CD4+CD25 high) in the peripheral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4 Lymphocyte Count
Share to CD4-Positive T-Lymphocytes
Share to Flow Cytometry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-2 Receptor alpha Subunit

Share to Neoplasms

Share to Prognosis

Share to Survival Analysis

Share to T-Lymphocytes, Regulatory

Source

Identifiers

PMID: 18404145

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD4+CD25high regulatory cells in peripheral blood of cancer patients.PMID 18404145Read ↗

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.Semantic proximity Read ↗

CD25+ CD4+ regulatory T-cells in cancer.Semantic proximity Read ↗

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.Semantic proximity Read ↗

CD4+CD25+ regulatory T cells: I. Phenotype and physiology.Semantic proximity Read ↗

CD4+CD25-FoxP3+T cells: a distinct subset or a heterogeneous population?Semantic proximity Read ↗

T regulatory cells control T‐cell proliferation partly by the release of soluble CD25 in patients with B‐cell malignanciesSemantic proximity Read ↗

Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood.Semantic proximity Read ↗

Regulatory T cells: a review.Semantic proximity Read ↗

Induced and natural regulatory T cells in human cancer.Semantic proximity Read ↗

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.Semantic proximity Read ↗

Functional features of human CD25+ regulatory thymocytes.Semantic proximity Read ↗

Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.